Burden and severity of respiratory syncytial virus infection in adults with cardiovascular diseases: A systematic literature review
Open Access
- 2 July 2025
- journal article
- review article
- Published by Elsevier in Progress in Cardiovascular Diseases
- Vol. 92, 130-143
Abstract
No abstract availableKeywords
Funding Information
- GlaxoSmithKline
This publication has 93 references indexed in Scilit:
- Burden of Respiratory Syncytial Virus Disease in Adults with Asthma and Chronic Obstructive Pulmonary Disease: A Systematic Literature ReviewCurrent Allergy and Asthma Reports, 2025
- RSV Risk Profile in Hospitalized Adults and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010–2022Infectious Diseases and Therapy, 2024
- Acute Cardiac Events in Hospitalized Older Adults With Respiratory Syncytial Virus InfectionJAMA Internal Medicine, 2024
- Estimated Respiratory Syncytial Virus-Related Hospitalizations and Deaths Among Children and Adults in Spain, 2016–2019Infectious Diseases and Therapy, 2024
- Comparative analysis of CRP as a biomarker of the inflammatory response intensity among common viral infections affecting the lungs: COVID-19 versus influenza A, influenza B and respiratory syncytial virusClinical and Experimental Medicine, 2023
- Incidence of Respiratory Syncytial Virus Infection in Older Adults Before and During the COVID-19 PandemicJAMA Network Open, 2023
- Severity of RSV infection in Southern European elderly patients during two consecutive winter seasons (2017–2018)Journal of Medical Virology, 2021
- Epidemiology of Heart FailureEuropean Journal of Heart Failure, 2020
- A Real-World Analysis of Patient Characteristics and Predictors of Hospitalization Among US Medicare Beneficiaries with Respiratory Syncytial Virus InfectionAdvances in Therapy, 2020
- Microorganisms associated with respiratory syncytial virus pneumonia in the adult populationEuropean Journal of Clinical Microbiology & Infectious Diseases, 2018